Sale and leaseback of headquarters building

By

Regulatory News | 11 Jul, 2022

Updated : 07:49

RNS Number : 9269R
Oxford Nanopore Technologies plc
11 July 2022
 

11 July 2022

 

Oxford Nanopore Technologies plc

 

("Oxford Nanopore")

 

Sale and leaseback of headquarters building to The Oxford Science Park

 

 

Oxford Nanopore Technologies plc (LSE: ONT), the company behind a new generation of molecular sensing technology based on nanopores, today announces that it has completed the sale of its interest in the Gosling Building (the "Property") to The Oxford Science Park (Properties) Limited ("TOSP") for £42.5 million.

 

On completion of the sale, TOSP will immediately grant Oxford Nanopore an occupational lease of the Property for 10 years; at a rent of £1.8 million per annum.

 

Tim Cowper, Chief Financial Officer of Oxford Nanopore, commented:

"We are pleased to have agreed the sale and leaseback of our headquarters building. The proceeds will be used for continued development of our core business."

 

 

-ends-

Enquiries:

 

Investors

ir@nanoporetech.com

 

Media

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

 

About Oxford Nanopore Technologies

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for real-time, high-performance, accessible and scalable analysis of DNA and RNA. The technology is used in more than 120 countries to understand the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses and whole environments.

 

For more information please visit: www.nanoporetech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSFFFISEESEIW

Last news